SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001546927-15-000095
Filing Date
2015-02-23
Accepted
2015-02-23 15:45:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 opaleye13gtrillumv1.txt SC 13G 14374
  Complete submission text file 0001546927-15-000095.txt   15793
Mailing Address 9B RUSSELL STREET CAMBRIDGE MA 02140
Business Address 9B RUSSELL STREET CAMBRIDGE MA 02140 617-997-9567
Opaleye Management Inc. (Filed by) CIK: 0001595855 (see all company filings)

IRS No.: 205648796 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9
Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SC 13G | Act: 34 | File No.: 005-88719 | Film No.: 15639598
SIC: 2834 Pharmaceutical Preparations